Thisconsultation continues aprocess begun in Seattle in October 2011. Itwill provide an opportunity to discuss past experience with large-scaleinterventions to expand RDT use, in both the public and the (formal andinformal) private sectors and in urban and rural settings. Additionally trajectories for expansion incountries where RDT use remains low will be discussed, focusing on questionssuch as whether the initial focus should be on the formal sectors (public andprivate) where there is greater likelihood of success, or on the informalsector where antimalarial use is greatest and where the potential for reducingdeaths and for decreasing inappropriate use of both antibiotics andantimalarials is also the greatest. RDT/ACT bundling at different levels of subsidy will also bediscussed. A third set of issues relatesto the trajectories for expanding RDT use in a world where there is ongoingfinancing for antimalarials but declining global health resources. Finally,with advice from participants, an agenda will be established for the following18 months of analytical work and consultations to better define how best tofinance and treat febrile illness in a world with possibly less malaria andcertainly fewer resources.
By invitation only.